Pure Global
NCT05642637

Biobank Cycle Collection

Biobank Cycle Collection Study From Women Trying to Conceive
SPD Development Company Limited·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Pregnancy
Study type
Observational
Sponsor & location
Primary sponsor
SPD Development Company Limited
Location
Bedford, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Dec 06, 2022
End date
Sep 01, 2024
Enrollment
260 participants
Primary outcome

Collection of daily urine samples from women trying to conceive

Summary

This study will provide daily urine samples from volunteers who are trying to conceive in
 order to maintain the SPD biobank.
 
 Study volunteers, seeking to conceive will be provided with a CE marked Clearblue Ovulation
 product to help them pinpoint their most fertile time and aid conception. All volunteers will
 provide daily early morning urine samples throughout the study period and keep a study diary
 of menses and pregnancy test results for up to 3 menstrual cycles.
 
 Urine samples will be received in the clinical laboratory and aliquoted and stored at -80˚C
 until required.

ICD-10 classifications
Pregnancy confirmedPregnancy-related condition, unspecifiedAbdominal pregnancyPregnancy, not (yet) confirmedOvarian pregnancy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05642637
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05642637 through Pure Global AI's free database. This phase not specified trial is sponsored by SPD Development Company Limited and is currently Recruiting. The study focuses on Pregnancy. Target enrollment is 260 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.